Jim Simons
CRMD icon

Jim Simons’s CorMedix CRMD Stock Holding History

Jim Simons’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$420K Buy
+54,577
New +$437K ﹤0.01% 2682
2025
Q3 		– Sell
-152,200
Closed -$1.88M – 3568
2025
Q2 		$1.88M Buy
+152,200
New +$1.68M ﹤0.01% 2149
2025
Q1 		– Sell
-134,000
Closed -$1.09M – 3521
2024
Q4 		$1.09M Buy
+134,000
New +$1.34M ﹤0.01% 2454
2024
Q3 		– Sell
-160,734
Closed -$696K – 3577
2024
Q2 		$696K Sell
160,734
-77,925
-33% -$396K ﹤0.01% 2526
2024
Q1 		$1.01M Buy
238,659
+2,959
+1% +$10.3K ﹤0.01% 2476
2023
Q4 		$886K Buy
235,700
+129,100
+121% +$444K ﹤0.01% 2487
2023
Q3 		$394K Buy
+106,600
New +$424K ﹤0.01% 2822
2023
Q2 		– Sell
-181,724
Closed -$752K – 3974
2023
Q1 		$752K Buy
181,724
+108,124
+147% +$442K ﹤0.01% 2656
2022
Q4 		$311K Buy
73,600
+60,000
+441% +$212K ﹤0.01% 3201
2022
Q3 		$38K Buy
+13,600
New +$56.6K ﹤0.01% 3817
2022
Q2 		– Sell
-10,157
Closed -$56K – 4269
2022
Q1 		$56K Buy
+10,157
New +$46.5K ﹤0.01% 3892
2021
Q4 		– Sell
-118,001
Closed -$549K – 3940
2021
Q3 		$549K Buy
+118,001
New +$687K ﹤0.01% 2855
2021
Q1 		– Sell
-43,700
Closed -$325K – 3366
2020
Q4 		$325K Buy
+43,700
New +$297K ﹤0.01% 3004
2020
Q2 		– Sell
-128,900
Closed -$463K – 3485
2020
Q1 		$463K Buy
128,900
+72,500
+129% +$410K ﹤0.01% 2794
2019
Q4 		$411K Buy
+56,400
New +$345K ﹤0.01% 2966
2015
Q2 		– Sell
-9,520
Closed -$468K – 3246
2015
Q1 		$468K Buy
+9,520
New +$226K ﹤0.01% 2620

Other funds holding CRMD

American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Jim Simons's CRMD Position: Q3 2026 in Review

Jim Simons opened a new position in CorMedix (CRMD) in Q3 2026: 54,577 shares worth $420K. The stake represents ﹤0.01% of the portfolio and ranks #2682 among its holdings. This is a return to the name: Jim Simons previously reported a position in CRMD as recently as Q2 2025.

Jim Simons first reported a position in CRMD in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.88M in Q2 2025. 109 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Jim Simons held 54,577 shares of CorMedix worth $420K as of Q3 2026.
  • CorMedix was a new Jim Simons position in Q3 2026.
  • CorMedix made up ﹤0.01% of Jim Simons's portfolio in Q3 2026, its #2682 holding.
  • Jim Simons first reported a position in CorMedix in Q1 2015 and has held it in 16 quarters since.
  • Jim Simons's CorMedix position peaked at $1.88M in Q2 2025.
  • 109 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.